- Home
- PRPO vs PAVM Comparison
PRPO vs PAVM Comparison
Compare PRPO & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- PAVM
- Stock Information
- Founded
- PRPO N/A
- PAVM 2014
- Country
- PRPO United States
- PAVM United States
- Employees
- PRPO N/A
- PAVM N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- PAVM Medical/Dental Instruments
- Sector
- PRPO Industrials
- PAVM Health Care
- Exchange
- PRPO Nasdaq
- PAVM Nasdaq
- Market Cap
- PRPO 9.5M
- PAVM 8.1M
- IPO Year
- PRPO N/A
- PAVM 2016
- Fundamental
- Price
- PRPO $6.25
- PAVM $1.08
- Analyst Decision
- PRPO
- PAVM Strong Buy
- Analyst Count
- PRPO 0
- PAVM 1
- Target Price
- PRPO N/A
- PAVM $21.00
- AVG Volume (30 Days)
- PRPO 7.5K
- PAVM 36.1K
- Earning Date
- PRPO 11-06-2024
- PAVM 11-13-2024
- Dividend Yield
- PRPO N/A
- PAVM N/A
- EPS Growth
- PRPO N/A
- PAVM N/A
- EPS
- PRPO N/A
- PAVM N/A
- Revenue
- PRPO $17,411,000.00
- PAVM $3,829,000.00
- Revenue This Year
- PRPO $75.18
- PAVM $70.80
- Revenue Next Year
- PRPO N/A
- PAVM $298.02
- P/E Ratio
- PRPO N/A
- PAVM N/A
- Revenue Growth
- PRPO 31.31
- PAVM 378.63
- 52 Week Low
- PRPO $4.31
- PAVM $0.60
- 52 Week High
- PRPO $8.49
- PAVM $4.88
- Technical
- Relative Strength Index (RSI)
- PRPO 52.41
- PAVM 54.36
- Support Level
- PRPO $6.14
- PAVM $1.01
- Resistance Level
- PRPO $6.47
- PAVM $1.21
- Average True Range (ATR)
- PRPO 0.19
- PAVM 0.08
- MACD
- PRPO 0.01
- PAVM 0.01
- Stochastic Oscillator
- PRPO 88.00
- PAVM 70.50
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.